Eva Maria del Amo, received her Ph.D. from the University of Helsinki with her dissertation “Ocular and Systemic Pharmacokinetic Models for Drug Discovery and Development” in 2015, and continued her research at the University of Eastern Finland, Kuopio in the ocular drug delivery research group under prof. Urtti’s supervision. In 2018, she moved to Manchester where she started a Marie-Curie fellowship on Pharmacokinetic-Pharmacodynamic models for patients with neovascular age-macular degeneration with anti-VEGF treatment, at the Centre for Applied Pharmacokinetic Research (CAPKR), at the University of Manchester under the menthorship of prof. Leon Aarons and Amin Rostami.
Her research interests include the application of modeling and simulation techniques to characterize the pharmacokinetics and pharmacodynamics of ocular drugs, guide dosage selection, and improve drug safety in patients with retinal diseases. Her computational models to describe and predict intravitreal pharmacokinetic in rabbits and humans have been followed and utilized by several small and big pharmaceutical companies as well as in Academia.
She has published 25 publications that include twelve peer reviewed scientific articles and seven reviews and four book chapters that have received >1140 citations. She is a reviewer for journals such Mol Pharm, Expert Opin Drug Deliv, Eur J Pharm Biopharm, Commun BioL and Drug Deliv Transl Res. At the moment, she is co-supervising four Ph.D. students in Finland and UK.